47 results on '"Miki, Shunichiro"'
Search Results
2. 10050-TB-1 ADDITIONAL RAS/MAPK PATHWAY ACTIVATION ALLOWS CELLS TO DIFFERENTIATE DURING TUMORIGENESIS.
3. Glioblastoma Mesenchymal Transition and Invasion are Dependent on a NF-κB/BRD2 Chromatin Complex
4. Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars
5. P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients
6. Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy
7. IL-1 TERT PROMOTER C228T MUTATION IN NEURAL PROGENITORS CONFERS GROWTH ADVANTAGE FOLLOWING TELOMERE SHORTENING IN VIVO
8. TB-1 ADDITIONAL GENETIC ALTERATIONS DIFFERENTIALLY ALTER THE TRANSCRIPTOMIC LANDSCAPE OF H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA
9. PATH-09. SUBTYPE-ASSOCIATED RNA SPLICING CONTROLLED BY GLIOMA DRIVER MUTATIONS REGULATES GLIOMAGENESIS
10. Abstract LB067: NF1 deletion potentiates tumorigenesis and activates expression of cancer-related kinases in an iPSC-based model of H3.3K27M diffuse intrinsic pontine glioma
11. Regulation of Glioblastoma Stem Cell Properties and Tumor Invasion by G ⍺12 Signaling
12. TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo
13. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
14. OTEH-9. scRNA sequencing of proneural GBM avatar model reveals acquisition of oncogenic transcriptional programming and infers a developmental path towards a genomically unstable state
15. HGG-12. HUMAN IPSC-DERIVED H3.3K27M NEUROSPHERES: A NOVEL MODEL FOR INVESTIGATING DIPG PATHOGENESIS AND DRUG RESPONSE
16. Targeting Glioblastoma Signaling and Metabolism with A Re-Purposed Brain-Penetrant Drug
17. TMOD-07. HUMAN DIFFUSE MIDLINE GLIOMA AVATARS AS A PLATFORM TO SEARCH FOR NOVEL THERAPEUTIC TARGETS
18. SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
19. Highly sensitive detection of TERT promoter mutations in recurrent glioblastomas using digital PCR
20. SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
21. Author Correction: Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells
22. Regulation of glioblastoma tumor growth and stem cell properties through Gα12: an upstream player in YAP signaling
23. Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells
24. Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
25. TMOD-09. MODELING TERT PROMOTER MUTATION IN ISOGENIC NEXT GENERATION GBM MODELS
26. TMOD-28. AUTHENTIC HUMAN GLIOMA MODELING USING GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS
27. Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts
28. Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
29. Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development
30. Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
31. IDH-wildtype infiltrative low-grade glial tumor with nodule-like enhancement pattern
32. Diffusely Infiltrating Cerebellar Anaplastic Astrocytoma Effectively Controlled with Bevacizumab: Case Report and Literature Review
33. Concomitant administration of radiation with eribulin improves the survival of mice harboring intracerebral glioblastoma
34. EXTH-50. DEVELOPMENT OF INVESTIGATOR INITIATED CLINICAL TRIAL OF TERT-TARGETING THERAPY USING ERIBULIN MESYLATE IN PATIENTS WITH RECURRENT GLIOBLASTOMA
35. Abstract 3117: Eribulin is a novel TERT-targeting inhibitor that penetrates into intracerebrally grown glioblastomas and suppresses their growth in mice
36. How to understand the Results of Basic Glioma Genome Sequence Data
37. EXTH-29. DEVELOPMENT OF TERT-TARGETING THERAPY AGAINST GLIOBLASTOMA
38. MPTH-22. SERUM 2-HYDROXYGLUTARATE (2HG) LEVELS ARE CORRELATED WITH TISSUE 2HG LEVELS IN ISOCITRATE DEHYDROGENASE 1 AND 2 GENES (IDH1/2)-MUTATED GLIOMAS BUT NOT IN IDH1/2-WILDTYPE GLIOMAS
39. EPIG-18PYROSEQUENCING ANALYSIS OF THE MGMT PROMOTER METHYLATION STATUS IN NEWLY DIAGNOSED GLIOBLASTOMA CORRELATES WITH VOLUMETRIC CHANGES OF UNRESECTED ENHANCED LESIONS IN MRI AFTER STANDARD RADIATION AND TEMOZOLOMIDE THERAPY
40. Photodynamic Diagnosis Using 5-Aminolevulinic Acid in 41 Biopsies for Primary Central Nervous System Lymphoma
41. Extreme volume expansion of a vestibular schwannoma due to intratumoral hemorrhage after gamma knife radiosurgery
42. Intraparenchymal brain lesion biopsy guided by a rigid endoscope and navigation system
43. Carotid artery stenting without post-stenting balloon dilatation
44. Coil-assist technique by using double microcatheters for a wide-necked ruptured anterior communicating artery aneurysm with a bleb arising from the neck
45. Sequential changes of Wallstent shape without post-stenting angioplasty
46. Encapsulated Acute Subdural Hematoma Mimicking Acute Epidural Hematoma on Computed Tomography
47. Carotid artery stenting without poststenting balloon dilatation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.